LLY

1,068.85

-0.32%↓

JNJ

207.25

+0.61%↑

ABBV

228.27

+0.5%↑

UNH

325.67

-0.54%↓

AZN

91.55

+0.22%↑

LLY

1,068.85

-0.32%↓

JNJ

207.25

+0.61%↑

ABBV

228.27

+0.5%↑

UNH

325.67

-0.54%↓

AZN

91.55

+0.22%↑

LLY

1,068.85

-0.32%↓

JNJ

207.25

+0.61%↑

ABBV

228.27

+0.5%↑

UNH

325.67

-0.54%↓

AZN

91.55

+0.22%↑

LLY

1,068.85

-0.32%↓

JNJ

207.25

+0.61%↑

ABBV

228.27

+0.5%↑

UNH

325.67

-0.54%↓

AZN

91.55

+0.22%↑

LLY

1,068.85

-0.32%↓

JNJ

207.25

+0.61%↑

ABBV

228.27

+0.5%↑

UNH

325.67

-0.54%↓

AZN

91.55

+0.22%↑

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Abierto

3.52 1.73

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.42

Máximo

3.6

Métricas clave
By Trading Economics
Ingresos	-3.3M -13M
Ventas	-1.4M 17M
BPA	-0.712
Margen de beneficios	-77.289
Empleados	260
EBITDA	4M -8.1M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+22.83% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-17M 104M
Apertura anterior	1.79
Cierre anterior	3.52

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 dic 2025, 17:29 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19 dic 2025, 16:47 UTC

Principales Movimientos del Mercado

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19 dic 2025, 16:10 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

21 dic 2025, 23:51 UTC

Charlas de Mercado

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

21 dic 2025, 23:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 dic 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

21 dic 2025, 23:35 UTC

Charlas de Mercado

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

19 dic 2025, 22:33 UTC

Ganancias

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19 dic 2025, 22:19 UTC

Ganancias

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19 dic 2025, 21:48 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 21:44 UTC

Ganancias

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 21:38 UTC

Ganancias

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19 dic 2025, 21:00 UTC

Charlas de Mercado

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19 dic 2025, 20:23 UTC

Charlas de Mercado

Oil Futures End Down Week on Up Note -- Market Talk

19 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19 dic 2025, 18:38 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19 dic 2025, 18:00 UTC

Charlas de Mercado

Ganancias

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19 dic 2025, 17:41 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 17:24 UTC

Charlas de Mercado

Ganancias

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

19 dic 2025, 16:29 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19 dic 2025, 16:20 UTC

Adquisiciones, fusiones, absorciones

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19 dic 2025, 16:19 UTC

Adquisiciones, fusiones, absorciones

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19 dic 2025, 16:18 UTC

Adquisiciones, fusiones, absorciones

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19 dic 2025, 16:16 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 dic 2025, 16:16 UTC

Charlas de Mercado

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19 dic 2025, 16:05 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 16:04 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 15:37 UTC

Charlas de Mercado

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

22.83% repunte

Estimación a 12 Meses

Media 4.25 USD 22.83%

Máximo 5.5 USD

Mínimo 3 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.